Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Shenouda

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentMarc Shenouda, Janice Robertson
Trends in Neurosciences|March 25, 2025
The long and the short of TDP-43Marc Shenouda, Paul M McKeever, Janice Robertson
Advances in Neurobiology|June 20, 2018
Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLDMarc Shenouda, Ashley B Zhang, Anna Weichert, et al.
Frontiers in Neuroscience|July 8, 2022
A C-Terminally Truncated TDP-43 Splice Isoform Exhibits Neuronal Specific Cytoplasmic Aggregation and Contributes to TDP-43 Pathology in ALSMarc Shenouda, Shangxi Xiao, Laura MacNair, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 18, 2026
Small molecule JRMS modulating importin-β1 chaperone activity as a therapeutic strategy reducing TDP-43 pathologyMarc Shenouda, Sandra Shenouda, Bryan Kartono, et al.
Acta Neuropathologica Communications|June 28, 2025
C9orf72 deficiency impairs the autophagic response to aggregated TDP-25 and exacerbates TDP-25-mediated neurodegeneration in vivoLilian Tsai-Wei Lin, Marc Shenouda, Philip McGoldrick, et al.
International Journal of Implant Dentistry|June 10, 2024
Round and flat zygomatic implants: effectiveness after a 3‑year follow‑up non‑interventional studyCarlos Aparicio, Waldemar D Polido, Antoine Chehade, et al.
Journal of Neurochemistry|January 17, 2020
Cellular models for discovering prion disease therapeutics: Progress and challengesSaffire H Krance, Russell Luke, Marc Shenouda, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentMarc Shenouda, Janice Robertson
Trends in Neurosciences|March 25, 2025
The long and the short of TDP-43Marc Shenouda, Paul M McKeever, Janice Robertson
Advances in Neurobiology|June 20, 2018
Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLDMarc Shenouda, Ashley B Zhang, Anna Weichert, et al.
Frontiers in Neuroscience|July 8, 2022
A C-Terminally Truncated TDP-43 Splice Isoform Exhibits Neuronal Specific Cytoplasmic Aggregation and Contributes to TDP-43 Pathology in ALSMarc Shenouda, Shangxi Xiao, Laura MacNair, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 18, 2026
Small molecule JRMS modulating importin-β1 chaperone activity as a therapeutic strategy reducing TDP-43 pathologyMarc Shenouda, Sandra Shenouda, Bryan Kartono, et al.
Acta Neuropathologica Communications|June 28, 2025
C9orf72 deficiency impairs the autophagic response to aggregated TDP-25 and exacerbates TDP-25-mediated neurodegeneration in vivoLilian Tsai-Wei Lin, Marc Shenouda, Philip McGoldrick, et al.
International Journal of Implant Dentistry|June 10, 2024
Round and flat zygomatic implants: effectiveness after a 3‑year follow‑up non‑interventional studyCarlos Aparicio, Waldemar D Polido, Antoine Chehade, et al.
Journal of Neurochemistry|January 17, 2020
Cellular models for discovering prion disease therapeutics: Progress and challengesSaffire H Krance, Russell Luke, Marc Shenouda, et al.
Pageof 1